Talphera (TLPH) Other Non-Current Assets (2010 - 2023)
Talphera (TLPH) posted quarterly Other Non-Current Assets of $1.9 million for Q4 2022, down 61.38% year-over-year from $5.0 million in Q4 2021, and up 669.32% quarter-over-quarter from $251000.0 in Q3 2022.
Talphera (TLPH) Other Non-Current Assets (2010 - 2023) Analysis & Trends
Talphera's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $1.9 million for Q4 2022.
- In Q4 2022, Other Non-Current Assets fell 61.38% year-over-year to $1.9 million; the TTM figure through Dec 2022 stood at $1.9 million (down 61.38% YoY), while the FY2022 annual figure was $1.9 million, down 61.38% from the prior year.
- Other Non-Current Assets for Q4 2022 stood at $1.9 million, up from $251000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.0 million in Q4 2020, with the low at $70000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $900000.0 (2019), against an average of $1.6 million.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets soared 594.44% in 2021, then sank 94.98% in 2022.
- Talphera's Other Non-Current Assets stood at $705000.0 in 2018, then surged by 68.51% to $1.2 million in 2019, then soared by 320.88% to $5.0 million in 2020, then changed by 0.0% to $5.0 million in 2021, then tumbled by 61.38% to $1.9 million in 2022.
- Business Quant data shows TLPH's Other Non-Current Assets at $1.9 million in Q4 2022, $251000.0 in Q3 2022, and $261000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Talphera | 90.35 Mn | 90.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 251,000.00 |
| Mar 31, 2022 | 261,000.00 |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 5.00 Mn |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 720,000.00 |
| Jun 30, 2020 | 784,000.00 |
| Mar 31, 2020 | 902,000.00 |
| Dec 31, 2019 | 1.19 Mn |
| Sep 30, 2019 | 984,000.00 |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 900,000.00 |
| Dec 31, 2018 | 705,000.00 |
| Sep 30, 2018 | 178,000.00 |